Structure

Physi-Chem Properties

Molecular Weight:  338.28
Volume:  384.313
LogP:  6.304
LogD:  4.255
LogS:  -3.069
# Rotatable Bonds:  14
TPSA:  46.53
# H-Bond Aceptor:  3
# H-Bond Donor:  1
# Rings:  1
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.256
Synthetic Accessibility Score:  3.462
Fsp3:  0.857
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.834
MDCK Permeability:  3.643511081463657e-05
Pgp-inhibitor:  0.005
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.045
20% Bioavailability (F20%):  0.999
30% Bioavailability (F30%):  0.994

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.23
Plasma Protein Binding (PPB):  98.17526245117188%
Volume Distribution (VD):  1.678
Pgp-substrate:  2.4713613986968994%

ADMET: Metabolism

CYP1A2-inhibitor:  0.385
CYP1A2-substrate:  0.289
CYP2C19-inhibitor:  0.373
CYP2C19-substrate:  0.083
CYP2C9-inhibitor:  0.317
CYP2C9-substrate:  0.952
CYP2D6-inhibitor:  0.2
CYP2D6-substrate:  0.337
CYP3A4-inhibitor:  0.787
CYP3A4-substrate:  0.107

ADMET: Excretion

Clearance (CL):  4.246
Half-life (T1/2):  0.515

ADMET: Toxicity

hERG Blockers:  0.377
Human Hepatotoxicity (H-HT):  0.173
Drug-inuced Liver Injury (DILI):  0.264
AMES Toxicity:  0.066
Rat Oral Acute Toxicity:  0.057
Maximum Recommended Daily Dose:  0.024
Skin Sensitization:  0.951
Carcinogencity:  0.117
Eye Corrosion:  0.494
Eye Irritation:  0.656
Respiratory Toxicity:  0.937

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC11796

Natural Product ID:  NPC11796
Common Name*:   (3S,4S,5S)-3-[(Z)-Hexadec-7-Enyl]-4-Hydroxy-5-Methyloxolan-2-One
IUPAC Name:   (3S,4S,5S)-3-[(Z)-hexadec-7-enyl]-4-hydroxy-5-methyloxolan-2-one
Synonyms:  
Standard InCHIKey:  BRHQPRAQLMOAKC-CAYSUEKXSA-N
Standard InCHI:  InChI=1S/C21H38O3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19-20(22)18(2)24-21(19)23/h10-11,18-20,22H,3-9,12-17H2,1-2H3/b11-10-/t18-,19-,20+/m0/s1
SMILES:  CCCCCCCC/C=CCCCCCC[C@H]1[C@@H]([C@H](C)OC1=O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL381644
PubChem CID:   44404760
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000050] Lactones
        • [CHEMONTID:0001245] Gamma butyrolactones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO1241 Laetia procera Species Salicaceae Eukaryota n.a. n.a. n.a. PMID[16168652]
NPO1241 Laetia procera Species Salicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens Activity = 65.9 uM PMID[556051]
NPT83 Cell Line MCF7 Homo sapiens Ratio = 2.1 n.a. PMID[556051]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Activity = 57.6 uM PMID[556051]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Activity = 27.5 uM PMID[556051]
NPT634 Organism Leishmania amazonensis Leishmania amazonensis Activity = 129.0 uM PMID[556051]
NPT634 Organism Leishmania amazonensis Leishmania amazonensis Activity = 111.0 uM PMID[556051]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC11796 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC218817
0.8961 High Similarity NPC200446
0.8831 High Similarity NPC209995
0.8701 High Similarity NPC469495
0.8514 High Similarity NPC42526
0.8493 Intermediate Similarity NPC209327
0.8493 Intermediate Similarity NPC273508
0.8415 Intermediate Similarity NPC475206
0.8356 Intermediate Similarity NPC104537
0.8356 Intermediate Similarity NPC22101
0.8356 Intermediate Similarity NPC271921
0.8356 Intermediate Similarity NPC330426
0.8356 Intermediate Similarity NPC127091
0.8356 Intermediate Similarity NPC148192
0.8312 Intermediate Similarity NPC81052
0.825 Intermediate Similarity NPC469920
0.8243 Intermediate Similarity NPC473559
0.8243 Intermediate Similarity NPC324981
0.8243 Intermediate Similarity NPC48218
0.8243 Intermediate Similarity NPC141481
0.8182 Intermediate Similarity NPC472966
0.8108 Intermediate Similarity NPC475443
0.8108 Intermediate Similarity NPC473829
0.8095 Intermediate Similarity NPC469483
0.8095 Intermediate Similarity NPC477994
0.8095 Intermediate Similarity NPC477993
0.8077 Intermediate Similarity NPC217725
0.8026 Intermediate Similarity NPC476660
0.8025 Intermediate Similarity NPC103634
0.8025 Intermediate Similarity NPC472948
0.7975 Intermediate Similarity NPC469514
0.7975 Intermediate Similarity NPC470899
0.7955 Intermediate Similarity NPC469645
0.7955 Intermediate Similarity NPC469692
0.7952 Intermediate Similarity NPC475947
0.7931 Intermediate Similarity NPC478004
0.7931 Intermediate Similarity NPC158388
0.7931 Intermediate Similarity NPC313670
0.7931 Intermediate Similarity NPC478003
0.7927 Intermediate Similarity NPC47031
0.7907 Intermediate Similarity NPC476707
0.7907 Intermediate Similarity NPC476706
0.7907 Intermediate Similarity NPC476803
0.7895 Intermediate Similarity NPC473772
0.7895 Intermediate Similarity NPC199557
0.7882 Intermediate Similarity NPC469910
0.7875 Intermediate Similarity NPC281296
0.7867 Intermediate Similarity NPC469925
0.7865 Intermediate Similarity NPC121825
0.7841 Intermediate Similarity NPC184463
0.7831 Intermediate Similarity NPC7414
0.7831 Intermediate Similarity NPC474252
0.7821 Intermediate Similarity NPC167145
0.7791 Intermediate Similarity NPC179659
0.7778 Intermediate Similarity NPC121200
0.7765 Intermediate Similarity NPC125290
0.7753 Intermediate Similarity NPC478036
0.7753 Intermediate Similarity NPC478037
0.775 Intermediate Similarity NPC49392
0.775 Intermediate Similarity NPC190400
0.775 Intermediate Similarity NPC279537
0.7727 Intermediate Similarity NPC15059
0.7727 Intermediate Similarity NPC474232
0.7722 Intermediate Similarity NPC330016
0.7722 Intermediate Similarity NPC474321
0.7711 Intermediate Similarity NPC470241
0.7701 Intermediate Similarity NPC201046
0.7701 Intermediate Similarity NPC476708
0.7692 Intermediate Similarity NPC474590
0.7692 Intermediate Similarity NPC477981
0.7692 Intermediate Similarity NPC477983
0.7683 Intermediate Similarity NPC19841
0.7683 Intermediate Similarity NPC89128
0.7683 Intermediate Similarity NPC470244
0.7683 Intermediate Similarity NPC469747
0.7683 Intermediate Similarity NPC263574
0.7683 Intermediate Similarity NPC201225
0.7683 Intermediate Similarity NPC470239
0.7674 Intermediate Similarity NPC475753
0.7671 Intermediate Similarity NPC174560
0.7671 Intermediate Similarity NPC125312
0.7671 Intermediate Similarity NPC201939
0.7662 Intermediate Similarity NPC144511
0.7662 Intermediate Similarity NPC296522
0.7654 Intermediate Similarity NPC474760
0.7654 Intermediate Similarity NPC7563
0.7654 Intermediate Similarity NPC116177
0.7654 Intermediate Similarity NPC320630
0.7647 Intermediate Similarity NPC9868
0.7647 Intermediate Similarity NPC158756
0.764 Intermediate Similarity NPC476705
0.764 Intermediate Similarity NPC30515
0.7632 Intermediate Similarity NPC473357
0.7632 Intermediate Similarity NPC193029
0.7625 Intermediate Similarity NPC324762
0.7625 Intermediate Similarity NPC199445
0.7619 Intermediate Similarity NPC474291
0.7619 Intermediate Similarity NPC89555
0.7614 Intermediate Similarity NPC307411
0.7614 Intermediate Similarity NPC473564
0.7614 Intermediate Similarity NPC52198
0.7614 Intermediate Similarity NPC77001
0.7614 Intermediate Similarity NPC117405
0.7614 Intermediate Similarity NPC253618
0.7609 Intermediate Similarity NPC40812
0.76 Intermediate Similarity NPC476654
0.76 Intermediate Similarity NPC476655
0.76 Intermediate Similarity NPC476657
0.759 Intermediate Similarity NPC233377
0.759 Intermediate Similarity NPC115418
0.7586 Intermediate Similarity NPC86005
0.7586 Intermediate Similarity NPC477959
0.7582 Intermediate Similarity NPC36954
0.7579 Intermediate Similarity NPC4620
0.7568 Intermediate Similarity NPC54925
0.7564 Intermediate Similarity NPC472955
0.7561 Intermediate Similarity NPC127526
0.7561 Intermediate Similarity NPC192006
0.7561 Intermediate Similarity NPC267231
0.7558 Intermediate Similarity NPC470755
0.7558 Intermediate Similarity NPC21469
0.7558 Intermediate Similarity NPC255307
0.7558 Intermediate Similarity NPC329738
0.7556 Intermediate Similarity NPC212486
0.7556 Intermediate Similarity NPC476300
0.7556 Intermediate Similarity NPC475912
0.7553 Intermediate Similarity NPC472753
0.7534 Intermediate Similarity NPC81896
0.7534 Intermediate Similarity NPC321919
0.7534 Intermediate Similarity NPC243532
0.7531 Intermediate Similarity NPC474447
0.7531 Intermediate Similarity NPC239127
0.7529 Intermediate Similarity NPC69469
0.7528 Intermediate Similarity NPC474761
0.7528 Intermediate Similarity NPC476004
0.7528 Intermediate Similarity NPC473448
0.7528 Intermediate Similarity NPC51004
0.7527 Intermediate Similarity NPC83895
0.7527 Intermediate Similarity NPC187761
0.75 Intermediate Similarity NPC476656
0.75 Intermediate Similarity NPC202672
0.75 Intermediate Similarity NPC476805
0.75 Intermediate Similarity NPC220964
0.75 Intermediate Similarity NPC473859
0.75 Intermediate Similarity NPC474551
0.75 Intermediate Similarity NPC475676
0.75 Intermediate Similarity NPC52861
0.75 Intermediate Similarity NPC472756
0.75 Intermediate Similarity NPC476659
0.75 Intermediate Similarity NPC88735
0.75 Intermediate Similarity NPC19136
0.7474 Intermediate Similarity NPC472754
0.7474 Intermediate Similarity NPC474747
0.7474 Intermediate Similarity NPC225353
0.7471 Intermediate Similarity NPC278283
0.7471 Intermediate Similarity NPC475461
0.7471 Intermediate Similarity NPC150755
0.7471 Intermediate Similarity NPC478112
0.7471 Intermediate Similarity NPC305475
0.747 Intermediate Similarity NPC82488
0.747 Intermediate Similarity NPC475210
0.747 Intermediate Similarity NPC98557
0.747 Intermediate Similarity NPC308545
0.747 Intermediate Similarity NPC99651
0.747 Intermediate Similarity NPC167881
0.747 Intermediate Similarity NPC164308
0.7468 Intermediate Similarity NPC320119
0.7467 Intermediate Similarity NPC68343
0.7467 Intermediate Similarity NPC328089
0.7444 Intermediate Similarity NPC12172
0.7444 Intermediate Similarity NPC208886
0.7442 Intermediate Similarity NPC295799
0.7442 Intermediate Similarity NPC70424
0.7442 Intermediate Similarity NPC165287
0.7442 Intermediate Similarity NPC114979
0.7442 Intermediate Similarity NPC243618
0.7442 Intermediate Similarity NPC141193
0.7442 Intermediate Similarity NPC474776
0.7442 Intermediate Similarity NPC476804
0.7442 Intermediate Similarity NPC96259
0.7442 Intermediate Similarity NPC191476
0.7439 Intermediate Similarity NPC240170
0.7439 Intermediate Similarity NPC120776
0.7432 Intermediate Similarity NPC321838
0.7423 Intermediate Similarity NPC478038
0.7416 Intermediate Similarity NPC97577
0.7416 Intermediate Similarity NPC256902
0.7416 Intermediate Similarity NPC474032
0.7416 Intermediate Similarity NPC118193
0.7412 Intermediate Similarity NPC475690
0.7407 Intermediate Similarity NPC255060
0.7407 Intermediate Similarity NPC228411
0.7403 Intermediate Similarity NPC26500
0.7403 Intermediate Similarity NPC99619
0.7397 Intermediate Similarity NPC470363
0.7396 Intermediate Similarity NPC474165
0.7396 Intermediate Similarity NPC475945
0.7396 Intermediate Similarity NPC69171
0.7396 Intermediate Similarity NPC475871
0.7396 Intermediate Similarity NPC110989

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC11796 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8148 Intermediate Similarity NPD5369 Approved
0.7841 Intermediate Similarity NPD7983 Approved
0.7831 Intermediate Similarity NPD6435 Approved
0.7831 Intermediate Similarity NPD4269 Approved
0.7831 Intermediate Similarity NPD4270 Approved
0.7738 Intermediate Similarity NPD7154 Phase 3
0.7703 Intermediate Similarity NPD3197 Phase 1
0.7674 Intermediate Similarity NPD5786 Approved
0.759 Intermediate Similarity NPD5368 Approved
0.759 Intermediate Similarity NPD4252 Approved
0.7558 Intermediate Similarity NPD5363 Approved
0.7416 Intermediate Similarity NPD6101 Approved
0.7416 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD5790 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD5784 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD46 Approved
0.7333 Intermediate Similarity NPD6698 Approved
0.7333 Intermediate Similarity NPD5785 Approved
0.7326 Intermediate Similarity NPD5362 Discontinued
0.7253 Intermediate Similarity NPD6411 Approved
0.7204 Intermediate Similarity NPD1698 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD4822 Approved
0.7176 Intermediate Similarity NPD4821 Approved
0.7176 Intermediate Similarity NPD4820 Approved
0.7176 Intermediate Similarity NPD4819 Approved
0.7174 Intermediate Similarity NPD5778 Approved
0.7174 Intermediate Similarity NPD5779 Approved
0.7143 Intermediate Similarity NPD4271 Approved
0.7143 Intermediate Similarity NPD3732 Approved
0.7143 Intermediate Similarity NPD4268 Approved
0.7033 Intermediate Similarity NPD5370 Suspended
0.7 Intermediate Similarity NPD7899 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD4250 Approved
0.7 Intermediate Similarity NPD4251 Approved
0.6979 Remote Similarity NPD4225 Approved
0.6966 Remote Similarity NPD1733 Clinical (unspecified phase)
0.6947 Remote Similarity NPD7839 Suspended
0.6944 Remote Similarity NPD3196 Approved
0.6944 Remote Similarity NPD4266 Approved
0.6944 Remote Similarity NPD3195 Phase 2
0.6944 Remote Similarity NPD3194 Approved
0.6889 Remote Similarity NPD4249 Approved
0.6882 Remote Similarity NPD4810 Clinical (unspecified phase)
0.6806 Remote Similarity NPD3172 Approved
0.68 Remote Similarity NPD6109 Phase 1
0.6796 Remote Similarity NPD6371 Approved
0.6778 Remote Similarity NPD6082 Clinical (unspecified phase)
0.6774 Remote Similarity NPD7838 Discovery
0.6742 Remote Similarity NPD5332 Approved
0.6742 Remote Similarity NPD5331 Approved
0.6737 Remote Similarity NPD5282 Discontinued
0.6731 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6712 Remote Similarity NPD3728 Approved
0.6712 Remote Similarity NPD3730 Approved
0.6705 Remote Similarity NPD4790 Discontinued
0.6702 Remote Similarity NPD7637 Suspended
0.6632 Remote Similarity NPD6399 Phase 3
0.6623 Remote Similarity NPD4246 Clinical (unspecified phase)
0.6588 Remote Similarity NPD8039 Approved
0.6574 Remote Similarity NPD7115 Discovery
0.6528 Remote Similarity NPD28 Approved
0.6528 Remote Similarity NPD29 Approved
0.6494 Remote Similarity NPD3198 Approved
0.6486 Remote Similarity NPD8513 Phase 3
0.6486 Remote Similarity NPD8515 Approved
0.6486 Remote Similarity NPD8516 Approved
0.6486 Remote Similarity NPD8517 Approved
0.6442 Remote Similarity NPD6686 Approved
0.642 Remote Similarity NPD7331 Phase 2
0.6413 Remote Similarity NPD1694 Approved
0.6375 Remote Similarity NPD7909 Approved
0.6364 Remote Similarity NPD6084 Phase 2
0.6364 Remote Similarity NPD6083 Phase 2
0.6344 Remote Similarity NPD7334 Approved
0.6344 Remote Similarity NPD6422 Discontinued
0.6344 Remote Similarity NPD7146 Approved
0.6344 Remote Similarity NPD7521 Approved
0.6344 Remote Similarity NPD5330 Approved
0.6344 Remote Similarity NPD6684 Approved
0.6344 Remote Similarity NPD6409 Approved
0.6316 Remote Similarity NPD1695 Approved
0.6304 Remote Similarity NPD4786 Approved
0.63 Remote Similarity NPD8029 Clinical (unspecified phase)
0.6289 Remote Similarity NPD5781 Clinical (unspecified phase)
0.6286 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6267 Remote Similarity NPD3729 Clinical (unspecified phase)
0.6264 Remote Similarity NPD5209 Approved
0.6264 Remote Similarity NPD3667 Approved
0.6263 Remote Similarity NPD5349 Clinical (unspecified phase)
0.625 Remote Similarity NPD3173 Approved
0.6224 Remote Similarity NPD7748 Approved
0.6211 Remote Similarity NPD6903 Approved
0.6211 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6207 Remote Similarity NPD8074 Phase 3
0.6204 Remote Similarity NPD8297 Approved
0.62 Remote Similarity NPD7902 Approved
0.619 Remote Similarity NPD6412 Phase 2
0.6186 Remote Similarity NPD7515 Phase 2
0.617 Remote Similarity NPD3618 Phase 1
0.6162 Remote Similarity NPD5695 Phase 3
0.6145 Remote Similarity NPD4247 Clinical (unspecified phase)
0.6139 Remote Similarity NPD5696 Approved
0.6136 Remote Similarity NPD819 Approved
0.6136 Remote Similarity NPD818 Approved
0.6132 Remote Similarity NPD6881 Approved
0.6132 Remote Similarity NPD6899 Approved
0.6129 Remote Similarity NPD5766 Clinical (unspecified phase)
0.6129 Remote Similarity NPD3133 Approved
0.6129 Remote Similarity NPD3666 Approved
0.6129 Remote Similarity NPD3665 Phase 1
0.6111 Remote Similarity NPD5343 Approved
0.6111 Remote Similarity NPD6649 Approved
0.6111 Remote Similarity NPD622 Approved
0.6111 Remote Similarity NPD6650 Approved
0.6106 Remote Similarity NPD6319 Approved
0.61 Remote Similarity NPD4792 Clinical (unspecified phase)
0.6098 Remote Similarity NPD7341 Phase 2
0.6098 Remote Similarity NPD2685 Clinical (unspecified phase)
0.6095 Remote Similarity NPD5739 Approved
0.6095 Remote Similarity NPD6675 Approved
0.6095 Remote Similarity NPD6402 Approved
0.6095 Remote Similarity NPD7128 Approved
0.6087 Remote Similarity NPD4800 Clinical (unspecified phase)
0.6087 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6075 Remote Similarity NPD6373 Approved
0.6075 Remote Similarity NPD6372 Approved
0.6071 Remote Similarity NPD7641 Discontinued
0.6064 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6053 Remote Similarity NPD8444 Approved
0.6042 Remote Similarity NPD6672 Approved
0.6042 Remote Similarity NPD5737 Approved
0.6038 Remote Similarity NPD5697 Approved
0.6034 Remote Similarity NPD8340 Approved
0.6034 Remote Similarity NPD8341 Approved
0.6034 Remote Similarity NPD8299 Approved
0.6034 Remote Similarity NPD8342 Approved
0.6034 Remote Similarity NPD7492 Approved
0.6022 Remote Similarity NPD6110 Phase 1
0.602 Remote Similarity NPD8035 Phase 2
0.602 Remote Similarity NPD8034 Phase 2
0.602 Remote Similarity NPD6079 Approved
0.6019 Remote Similarity NPD7102 Approved
0.6019 Remote Similarity NPD7290 Approved
0.6019 Remote Similarity NPD6421 Discontinued
0.6019 Remote Similarity NPD5344 Discontinued
0.6019 Remote Similarity NPD6883 Approved
0.6 Remote Similarity NPD5279 Phase 3
0.6 Remote Similarity NPD4802 Phase 2
0.6 Remote Similarity NPD4238 Approved
0.5983 Remote Similarity NPD6616 Approved
0.5983 Remote Similarity NPD8451 Approved
0.5981 Remote Similarity NPD7320 Approved
0.598 Remote Similarity NPD7638 Approved
0.5979 Remote Similarity NPD5328 Approved
0.5965 Remote Similarity NPD6054 Approved
0.5963 Remote Similarity NPD6869 Approved
0.5963 Remote Similarity NPD8130 Phase 1
0.5963 Remote Similarity NPD6617 Approved
0.5963 Remote Similarity NPD1719 Phase 1
0.5963 Remote Similarity NPD6847 Approved
0.5957 Remote Similarity NPD6400 Clinical (unspecified phase)
0.5955 Remote Similarity NPD6933 Approved
0.5948 Remote Similarity NPD7642 Approved
0.5948 Remote Similarity NPD8328 Phase 3
0.5948 Remote Similarity NPD7829 Approved
0.5948 Remote Similarity NPD7830 Approved
0.5938 Remote Similarity NPD7524 Approved
0.5932 Remote Similarity NPD8448 Approved
0.5932 Remote Similarity NPD7078 Approved
0.5926 Remote Similarity NPD6014 Approved
0.5926 Remote Similarity NPD6012 Approved
0.5926 Remote Similarity NPD8132 Clinical (unspecified phase)
0.5926 Remote Similarity NPD6013 Approved
0.5922 Remote Similarity NPD7640 Approved
0.5922 Remote Similarity NPD7639 Approved
0.5918 Remote Similarity NPD5207 Approved
0.5909 Remote Similarity NPD6882 Approved
0.59 Remote Similarity NPD7901 Clinical (unspecified phase)
0.59 Remote Similarity NPD7900 Approved
0.589 Remote Similarity NPD6125 Clinical (unspecified phase)
0.5888 Remote Similarity NPD5701 Approved
0.5888 Remote Similarity NPD6685 Approved
0.5882 Remote Similarity NPD7736 Approved
0.587 Remote Similarity NPD8259 Clinical (unspecified phase)
0.5862 Remote Similarity NPD6370 Approved
0.5859 Remote Similarity NPD5284 Approved
0.5859 Remote Similarity NPD5281 Approved
0.5856 Remote Similarity NPD4632 Approved
0.5847 Remote Similarity NPD8273 Phase 1
0.5842 Remote Similarity NPD4629 Approved
0.5842 Remote Similarity NPD5210 Approved
0.5842 Remote Similarity NPD6356 Clinical (unspecified phase)
0.5841 Remote Similarity NPD8137 Clinical (unspecified phase)
0.5841 Remote Similarity NPD8295 Clinical (unspecified phase)
0.5833 Remote Similarity NPD39 Approved
0.5833 Remote Similarity NPD6011 Approved
0.5833 Remote Similarity NPD634 Phase 3
0.5833 Remote Similarity NPD6098 Approved
0.5833 Remote Similarity NPD3174 Discontinued
0.5833 Remote Similarity NPD4222 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data